Adam Friedman- Cutaneous Dysbiosis

Adam Friedman- Cutaneous Dysbiosis

Dr. Friedman discusses how inflammatory skin disease, such as acne, rosacea, psoriasis, and atopic dermatitis, can be associated or even caused by reduced cutaneous bacterial diversity.


April 2020 Editorial Message

Articles from current issue

Letter to the Editor: A Case of Morbilliform Drug Eruption to Dulaglutide

Dear Editor: Dulaglutide is a glucagon-like peptide (GLP-1) receptor agonist, which stimulates insulin release via activation of GLP-1 receptors on pancreatic beta cells. Here, we report the first case of morbilliform drug eruption to dulaglutide. Case presentation. An 84-year-old male patient with a medical history of Type 2 diabetes mellitus, hyperlipidemia, hypertension, and back pain

Continue Reading »

Examining 15% Azelaic Acid Foam for the Treatment of Folliculitis: A Pilot Study

J Clin Aesthet Dermatol. 2020;13(4):36–38 by Zoe Diana Draelos, MD Dr. Draelos is with Dermatology Consulting Services, PLLC in High Point, North Carolina. FUNDING: Funding was provided by Leo Pharma. DISCLOSURES: The authors have no conflicts of interest relevant to the content of this article. ABSTRACT: Background. Folliculitis is a frequently recurrent skin condition characterized

Continue Reading »

Rowell Syndrome: A Diagnostic Challenge

J Clin Aesthet Dermatol. 2020;13(4):40–42 by Lucia Gallo, MD; Matteo Megna, MD; Bianca Festa, MD; Pio Stellato, MD; Rosita Di Pinto, MD; Gabriella Fabbrocini, MD; and Maria Ferrillo, MD Drs. Gallo, Megna, Festa, Fabbrocini, and Ferrillo are with the Section of Dermatology in the Department of Clinical Medicine and Surgery at the University of Naples

Continue Reading »


Emerging Authors


The Journal of Clinical and Aesthetic Dermatology – Providing dermatologists with peer-reviewed, evidence-based information on the latest techniques, and cutting-edge practice management solutions.